Ana Catarina Fonseca is a neurology consultant and has a PhD in Medicine, from the Faculty of Medicine, University of Lisbon (2014). In 2014, she completed a Masters in Public Health from Harvard University (USA), having previously completed two masters: in Stroke Medicine at the University Danube Krems (Austria) and in Neuroscience at the University of Lisbon. She is a researcher at the Instituto de Medicina Molecular where she manages the stroke biobank collection, teaches Pharmacology and Neurology at the Faculty of Medicine (University of Lisbon) and works at the stroke unit of Hospital de Santa Maria in Lisbon, Portugal. She participated in the “value of treatment project” of the European Brain Council” and in the writing of guidelines for the “European Stroke Organization”. She is an editorial board member for Stroke and BMC Neurology. Her main research interests are cryptogenic stroke, heart-brain interactions and precision medicine.